1-6 of 6
U. Keilholz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intermittent Low-Dose IFN Gamma Treatment for Metastatic Renal Cell Carcinoma: Analysis of Factors Predicting Clinical Response and Long-Term Survival

Available to Purchase
Subject Area:
Oncology
W.E. Aulitzky, W. Aulitzky, J. Ellerhorst, C. Logothetis, A. Gomahr, M. Stöckle, O. Thews, C. Scheibenbogen, U. Keilholz, C. Huber
Journal: Onkologie
Onkologie (1995) 18 (4): 339–345.
https://doi.org/10.1159/000218614
Published Online: 11 May 2009
View articletitled, Intermittent Low-Dose IFN Gamma Treatment for Metastatic Renal Cell Carcinoma: Analysis of Factors Predicting Clinical Response and Long-Term Survival
Open the PDF for Intermittent Low-Dose IFN Gamma Treatment for Metastatic Renal Cell Carcinoma: Analysis of Factors Predicting Clinical Response and Long-Term Survival in another window
Journal Articles

Phase II Study of Intermittent Low-Dose IFN-gamma in Metastatic Renal Cell Cancer

Available to Purchase
Subject Area:
Oncology
C. Scheibenbogen, U. Keilholz, D. Maclachlan, T. Möhler, P. Brossart, W. Hunstein
Journal: Onkologie
Onkologie (1993) 16 (6): 461–464.
https://doi.org/10.1159/000218307
Published Online: 08 May 2009
View articletitled, Phase II Study of Intermittent Low-Dose IFN-gamma in Metastatic Renal Cell Cancer
Open the PDF for Phase II Study of Intermittent Low-Dose IFN-gamma in Metastatic Renal Cell Cancer in another window
Journal Articles

Interleukin-2 in Combination with Interferon-Alpha in Disseminated Malignant Melanoma and Advanced Renal Cell Carcinoma: A Phase I/II Study

Available to Purchase
Subject Area:
Oncology
L. Bergmann, E. Weidmann, P.S. Mitrou, U. Runne, U. Keilholz, H.H. Bartsch, C.R. Franks
Journal: Onkologie
Onkologie (1990) 13 (2): 137–140.
https://doi.org/10.1159/000216741
Published Online: 28 April 2009
View articletitled, Interleukin-2 in Combination with Interferon-Alpha in Disseminated Malignant Melanoma and Advanced Renal Cell Carcinoma: A Phase I/II Study
Open the PDF for Interleukin-2 in Combination with Interferon-Alpha in Disseminated Malignant Melanoma and Advanced Renal Cell Carcinoma: A Phase I/II Study in another window
Journal Articles

Erste Erfahrungen mit Docetaxel in der Behandlung des fortgeschrittenen oder rezidivierten Ösophaguskarzinoms

Free
Subject Area:
Oncology
U. Keilholz
Journal: Onkologie
Onkologie (2000) 23 (Suppl. 6): 43–44.
https://doi.org/10.1159/000055077
Published Online: 17 November 2004
View articletitled, Erste Erfahrungen mit Docetaxel in der Behandlung des fortgeschrittenen oder rezidivierten Ösophaguskarzinoms
Open the PDF for Erste Erfahrungen mit Docetaxel in der Behandlung des fortgeschrittenen oder rezidivierten Ösophaguskarzinoms in another window
Journal Articles

Phase I Dose Escalation Study of Carboplatin to a Fixed Dose of Irinotecan as First-Line Treatment of Small Cell Lung Cancer

Available to Purchase
Subject Area:
Oncology
A. Schmittel, K. Schulze, G. Hütter, P. Krebs, E. Thiel, U. Keilholz
Journal: Onkologie
Onkologie (2004) 27 (3): 280–284.
https://doi.org/10.1159/000077979
Published Online: 05 July 2004
View articletitled, Phase I Dose Escalation Study of Carboplatin to a Fixed Dose of Irinotecan as First-Line Treatment of Small Cell Lung Cancer
Open the PDF for Phase I Dose Escalation Study of Carboplatin to a Fixed Dose of Irinotecan as First-Line Treatment of Small Cell Lung Cancer in another window
Journal Articles

Rational Development of Peptide Vaccination in Clinical Oncology. Concerning Jäger E, et al.: Peptide vaccination in clinical oncology. Onkologie 2000;23:410–415.

Free
Subject Area:
Oncology
U. Keilholz, C. Scheibenbogen, E. Thiel, D. Schadendorf
Journal: Onkologie
Onkologie (2001) 24 (2): 174.
https://doi.org/10.1159/000050308
Published Online: 11 May 2001
View articletitled, Rational Development of Peptide Vaccination in Clinical Oncology. Concerning Jäger E, et al.: Peptide vaccination in clinical oncology. Onkologie 2000;23:410–415.
Open the PDF for Rational Development of Peptide Vaccination in Clinical Oncology. Concerning Jäger E, et al.: Peptide vaccination in clinical oncology. Onkologie 2000;23:410–415. in another window